BiotechTube
Home/Verastem Oncology/Dan Paterson
DP

Dan Paterson

President and Chief Executive Officer

Verastem Oncology

Therapeutic Areas

OncologyRAS/MAPK Pathway-Driven Cancers

Verastem Oncology Pipeline

DrugIndicationPhase
Avutometinib + DefactinibKRAS-mutant recurrent Low-Grade Serous Ovarian Cancer (LGSOC)Approved
Avutometinib + SotorasibKRAS G12C-mutant NSCLCPhase 1/2
Avutometinib + AdagrasibKRAS G12C-mutant NSCLCPhase 1/2

Leadership Team at Verastem Oncology

DC
Dan Calkins
Chief Financial Officer
CC
Cathy Carew
Chief Organizational Effectiveness Officer
FS
Faye Seyedi
Head of Chemistry, Manufacturing and Controls
View full Verastem Oncology profile